Identification of Biomarkers for the Diagnosis of Sepsis-Associated Acute Kidney Injury and Prediction of Renal Recovery in the Intensive Care Unit

키워드

참고문헌 (45)

1. Bozza S, "A crucial role for tryptophan catabolism at the host", Candida albicans interface, 2005, pp.174, 2910~2918
2. Brown RR, "Kynurenine and serotonin pathways. Advances in experimental medicine and biology", pp.425~435 (1991), Springer
3. Cole L, "A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a"closed"ICU system", Am J Respir Crit Care Med, 162, pp.191~196 (2000)
4. Schrier RW, "Acute renal failure and sepsis", N Engl J Med, 351, pp.159~169 (2004)
5. Swaminathan M, "Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury", Ann Thorac Surg, 89, pp.1098~1104 (2010)
6. Baxmann AC, "Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C", Clin J Am Soc Nephrol, 3, pp.348~354 (2008)
7. Badawy AA, "Kynurenine pathway of tryptophan metabolism : regulatory and functional aspects", Int J Tryptophan Res, 10, pp.1178646917691938~ (2017)
8. Xiaozhong Zheng, "Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury", Experimental and Molecular Medicine, 51, pp.1~14 (2019), 생화학분자생물학회[DOI]
9. Thevandavakkam MA, "Targeting kynurenine 3-monooxygenase(KMO) : implications for therapy in Huntington’s disease", CNS Neurol Disord Drug Targets, 9, pp.791~800 (2010)
10. Zhao J, "Simultaneous determination of plasma creatinine, uric acid, kynurenine and tryptophan by high-performance liquid chromatography : method validation and in application to the assessment of renal function", Biomed Chromatogr, 29, pp.410~415 (2015)
11. Zhao J, "Plasma kynurenic acid", tryptophan ratio : a sensitive and reliable biomarker for the assessment of renal function, 2013, pp.35, 648~653
12. Reichetzeder C, "Pre-interventional kynurenine predicts medium-term outcome after contrast media exposure due to coronary angiography", Kidney Blood Press Res, 42, pp.244~256 (2017)
13. Wang Q, "Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation", Front Biosci(Landmark Ed), 20, pp.1116~1143 (2015)
14. Pawlak K, "The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease", Atherosclerosis, 204, pp.309~314 (2009)
15. Lögters TT, "Increased plasma kynurenine values and kynurenine-tryptophan ratios after major trauma are early indicators for the development of sepsis", Shock, 32, pp.29~34 (2009)
16. Dabrowski W, "Changes in plasma kynurenic acid concentration in septic shock patients undergoing continuous veno-venous haemofiltration", Inflammation, 37, pp.223~234 (2014)
17. Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40, pp.373~383 (1987)
18. Singer M, "The third international consensus definitions for sepsis and septic shock(sepsis-3)", JAMA, 315, pp.801~810 (2016)
19. Khwaja A, "KDIGO clinical practice guidelines for acute kidney injury", Nephron Clin Pract, 120, pp.c179~c184 (2012)
20. Chawla LS, "Acute kidney disease and renal recovery : consensus report of the acute disease quality initiative(ADQI)16 workgroup", Nat Rev Nephrol, 13, pp.241~257 (2017)
21. Bagshaw SM, "Early acute kidney injury and sepsis : a multicentre evaluation", Crit Care, 12, pp.R47~ (2008)
22. Neveu H, "Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study", Nephrol Dial Transplant, 11, pp.293~299 (1996)
23. Oppert M, "Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality : results from the German prevalence study", Nephrol Dial Transplant, 23, pp.904~909 (2008)
24. Díaz de León M, "Severe sepsis as a cause of acute renal failure", Nefrologia, 26, pp.439~444 (2006)
25. Bagshaw SM, "Acute kidney injury in septic shock : clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy", Intensive Care Med, 35, pp.871~881 (2009)
26. Parmar A, "Epidemiology of septic acute kidney injury", Curr Drug Targets, 10, pp.1169~1178 (2009)
27. Lopes JA, "Acute kidney injury in patients with sepsis : a contemporary analysis", Int J Infect Dis, 13, pp.176~181 (2009)
28. Schiffl H, "Five-year outcomes of severe acute kidney injury requiring renal replacement therapy", Nephrol Dial Transplant, 23, pp.2235~2241 (2008)
29. Aregger F, "Increased urinary excretion of kynurenic acid is associated with non-recovery from acute kidney injury in critically ill patients", BMC Nephrol, 19, pp.44~ (2018)
30. Trabanelli S, "Induction of regulatory T cells by dendritic cells through indoleamine 2, 3-dioxygenase : a potent mechanism of acquired peripheral tolerance", Curr Med Chem, 18, pp.2234~2239 (2011)
31. Zaher SS, "3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival", Invest Ophthalmol Vis Sci, 52, pp.2640~2648 (2011)
32. Sakash JB, "Cytokines induce indoleamine 2, 3-dioxygenase expression in human atheroma-asociated cells : implications for persistent Chlamydophila pneumoniae infection", Infect Immun, 70, pp.3959~3961 (2002)
33. Narui K, "Anti-infectious activity of tryptophan metabolites in the L-tryptophan-L-kynurenine pathway", Biol Pharm Bull, 32, pp.41~44 (2009)
34. Lendemans S, "Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor(GM-CSF), granulocyte colony-stimulating factor(G-CSF)and interferon gamma(IFNgamma)after severe trauma", Inflamm Res, 56, pp.38~44 (2007)
35. Hotchkiss RS, "The pathophysiology and treatment of sepsis", N Engl J Med, 348, pp.138~150 (2003)
36. Holmes EW, "Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography", Anal Biochem, 172, pp.518~525 (1988)
37. Gonçalves M, "Serum lactates and acute kidney injury in patients with sepsis : a cohort analysis", Cogent Med, 4, pp.1388209~ (2017)
38. Plataki M, "Predictors of acute kidney injury in septic shock patients : an observational cohort study", Clin J Am Soc Nephrol, 6, pp.1744~1751 (2011)
39. Hsu YC, "Septic acute kidney injury patients in emergency department : the risk factors and its correlation to serum lactate", Am J Emerg Med, 37, pp.204~208 (2019)
40. Rishu AH, "Even mild hyperlactatemia is associated with increased mortality in critically ill patients", Crit Care, 17, pp.R197~ (2013)
41. Jones AE, "Sepsis-induced tissue hypoperfusion", Crit Care Nurs Clin North Am, 23, pp.115~125 (2011)
42. Levy B, "Lactate and shock state : the metabolic view", Curr Opin Crit Care, 12, pp.315~321 (2006)
43. Garcia-Alvarez M, "Sepsis-associated hyperlactatemia", Crit Care, 18, pp.503~ (2014)
44. Zarbock A, "Sepsis-induced acute kidney injury revisited : pathophysiology, prevention and future therapies", Curr Opin Crit Care, 20, pp.588~595 (2014)
45. Bellomo R, "Acute kidney injury in sepsis", Intensive Care Med, 43, pp.816~828 (2017)

관련 논문AI추천